Fujisawa Inc, released data recently that supports the safety and efficacy of Protopic (tacrolimus ointment) 0.03 percent concentration in children with mild to moderate atopic dermatitis.
FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum
The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma
What’s New in Pediatric Dermatology With Elizabeth (Lisa) Swanson, MD
The Cutaneous Connection: Episode 7- Tips and Tricks for Treating Young Skin of Color Patients
Non-Invasive Test That May Help Predict Eczema in Babies
Treatment of Plaque Psoriasis in Children
2 Clarke Drive Cranbury, NJ 08512